What is the recommended treatment for brucellosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brucellosis Treatment

For uncomplicated brucellosis, the optimal first-line treatment is doxycycline 100 mg twice daily orally for 6 weeks combined with streptomycin 15 mg/kg daily intramuscularly for 2-3 weeks, which achieves the lowest relapse rates. 1, 2

First-Line Treatment Regimens

Preferred Option: Doxycycline-Streptomycin

  • Doxycycline 100 mg twice daily orally for 6 weeks PLUS streptomycin 15 mg/kg daily intramuscularly for 2-3 weeks 1, 2
  • This combination demonstrates superior efficacy with the lowest relapse rates compared to all other regimens 2, 3
  • Meta-analysis shows doxycycline-streptomycin is significantly better than doxycycline-rifampicin (OR = 3.17; 95% CI = 2.05-4.91) 3

Alternative First-Line Option: Doxycycline-Gentamicin

  • Doxycycline 100 mg twice daily orally for 6 weeks PLUS gentamicin 5 mg/kg daily parenterally as a single dose for 7 days 1, 2
  • The World Health Organization recommends this as first-line with comparable efficacy to doxycycline-streptomycin 1
  • Gentamicin offers the advantage of wider availability and shorter duration of parenteral therapy (7 days vs 14-21 days) 1
  • No significant difference in outcomes between gentamicin and streptomycin regimens (OR = 1.89; 95% CI = 0.81-4.39) 3
  • Use weight-based dosing of 5 mg/kg daily; fixed 500 mg dosing is not recommended 1

Second-Choice Regimen: Doxycycline-Rifampicin

  • Doxycycline 100 mg twice daily orally for 6 weeks PLUS rifampicin 600-900 mg daily as a single morning dose for 6 weeks 1, 2
  • This all-oral regimen is more convenient but has higher relapse rates than aminoglycoside-containing regimens 2, 3
  • Important caveat: In regions where tuberculosis is endemic, avoid rifampicin due to risk of promoting mycobacterial resistance 1, 2

Second-Line Treatment Options

Doxycycline-Trimethoprim-Sulfamethoxazole

  • Doxycycline 100 mg twice daily PLUS trimethoprim-sulfamethoxazole 800+160 mg twice daily for 6 weeks 1
  • The Centers for Disease Control and Prevention suggests this as a cost-effective alternative in resource-limited settings with response rates above 90% 1
  • Comparable efficacy to doxycycline-rifampicin in systematic reviews 4, 3

Quinolone-Containing Regimens

  • Ofloxacin or ciprofloxacin combined with doxycycline or rifampicin 1
  • The European Centre for Disease Prevention and Control advises reserving these as second or third agents due to higher cost and antimicrobial resistance concerns 1
  • Similar efficacy to doxycycline-rifampicin but with higher relapse rates 4, 3

Treatment Duration and Monitoring

Standard Duration

  • 6 weeks is the standard treatment duration for uncomplicated brucellosis 1, 2
  • Shorter durations (3-4 weeks) are inadequate and associated with unacceptably high relapse rates of 22% vs 4.8% 2, 4

Expected Outcomes

  • Relapse rates range from 5-15% even with appropriate treatment 1, 2
  • Relapses are usually mild and respond to retreatment with the same regimens 1, 2
  • Clinical improvement should be evident within 7-14 days of treatment initiation 5

Special Populations

Children Under 8 Years Old

  • Rifampicin 600-900 mg daily PLUS trimethoprim-sulfamethoxazole for 6 weeks 6, 4
  • Alternative: Rifampicin for 6 weeks PLUS gentamicin 5-6 mg/kg/day for 5-7 days 6, 4
  • Tetracyclines are contraindicated due to dental staining risk 6, 7

Pregnant Women

  • Rifampicin 900 mg once daily for 6 weeks as monotherapy 6, 7
  • Tetracyclines are contraindicated in pregnancy 6, 7

Complicated Brucellosis

Brucellar Spondylitis (Spinal Involvement)

  • Extend treatment duration to 12 weeks (3 months) 2
  • Aminoglycoside-containing regimens may be superior to rifampicin-containing regimens 2
  • The Infectious Diseases Society of America recommends MRI to confirm spinal involvement before extending therapy 2
  • Always assess for back pain in brucellosis patients, as it may indicate spondylitis requiring prolonged treatment 2

Brucellar Endocarditis

  • High mortality complication requiring aggressive antimicrobial therapy 2
  • Surgical intervention needed in most cases 2, 6

Other Focal Complications

  • Neurobrucellosis, cerebral abscess, epidural abscess, or splenic abscess may require surgical intervention if antibiotic-resistant 6, 7
  • Treatment duration typically extended to 12-24 weeks 2

Common Pitfalls to Avoid

Monotherapy

  • Never use monotherapy for brucellosis 4
  • Monotherapy has significantly higher relapse rates (13% vs 4.8% for combination therapy) 4

Inadequate Duration

  • Do not shorten treatment below 6 weeks for uncomplicated cases 2, 4
  • Short-term regimens (less than 4 weeks) have relapse rates of 22% vs 4.8% for standard duration 4

Symptom Management

  • Fever with afternoon temperature swings and profuse sweating is expected during early treatment and represents ongoing inflammatory response, not treatment failure 5
  • Acetaminophen can manage fever and discomfort 5
  • Full symptom resolution may take several weeks despite appropriate therapy 5

References

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Brucellosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Fever and Chills in Brucellosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of human brucellosis.

Le Journal medical libanais. The Lebanese medical journal, 2000

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.